CIPLA ELEVATES SHIVAM PURI TO LEAD ONE INDIA BUSINESS

Cipla has appointed Shivam Puri, currently Managing Director and CEO of Cipla Health, as Chief Executive Officer of its One India Business effective 1 July 2026. Puri’s leadership at Cipla Health transformed the subsidiary into a leading wellness company, bringing over two decades of FMCG and healthcare expertise to his new role.

Cipla Limited has announced a significant leadership move with the appointment of Shivam Puri as Chief Executive Officer of its One India Business, effective 1 July 2026. The development was confirmed in a filing to the Bombay Stock Exchange, underscoring the company’s intent to strengthen its domestic operations under seasoned leadership.  

Puri, who currently serves as Managing Director and CEO of Cipla Health Limited, has been instrumental in shaping the consumer healthcare subsidiary since taking charge in 2019. Over the past seven years, he has overseen its transformation from a fledgling startup into one of India’s leading fast-moving wellness goods companies. Cipla Health’s portfolio now spans diverse consumer categories including smoking cessation, pain care, cough and cold, skincare, haircare and nutrition, reflecting Puri’s ability to identify and scale high-potential segments.  

His appointment to lead Cipla’s One India Business marks a strategic step in aligning the company’s prescription and consumer healthcare strengths. With over 23 years of leadership experience across both FMCG and healthcare, Puri brings a blend of commercial acumen and consumer-centric expertise that is expected to drive growth in India’s evolving pharmaceutical and wellness landscape.  

Prior to joining Cipla Health, Puri held senior leadership roles at Hindustan Unilever Limited, Jubilant FoodWorks Limited and ITC Limited. This cross-sectoral experience has equipped him with a deep understanding of brand building, consumer engagement and operational excellence, qualities that Cipla is keen to leverage as it consolidates its position in the Indian market.  

Cipla Health’s rapid rise under Puri’s stewardship has been widely noted in the industry. By expanding into everyday wellness categories and strengthening distribution, he positioned the subsidiary as a trusted name in consumer healthcare. His ability to combine innovation with accessibility has resonated with Indian consumers, setting a strong precedent for his new mandate.  

The One India Business, which encompasses Cipla’s domestic pharmaceutical operations, is a critical growth driver for the company. Puri’s elevation signals Cipla’s intent to integrate consumer insights more deeply into its prescription business, while also reinforcing its commitment to building a holistic healthcare ecosystem.  

As Cipla prepares for its next phase of growth, Puri’s leadership is expected to play a pivotal role in navigating competitive pressures, regulatory dynamics and shifting consumer expectations. His track record of scaling businesses and creating value across sectors positions him as a key architect of Cipla’s India strategy in the coming years.